Reaction

Mitral Valve Prolapse reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,646 reports · 29 co-occurring drugs

As of the last recalculation, Mitral Valve Prolapse appears in 1,646 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 34.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Alendronate Sodium23634.434.4
Meperidine Hydrochloride1318.018.0
Etonogestrel And Ethinyl Estradiol2816.216.2
Ascorbic Acid2815.515.5
Hyoscyamine Sulfate1115.215.3
Tolterodine Tartrate912.712.8
Raloxifene Hydrochloride1412.212.2
Carisoprodol1812.112.1
Conjugated Estrogens And Medroxyprogesterone Acetate2211.911.9
Diphenoxylate Hydrochloride And Atropine Sulfate1211.211.2
Sodium Oxybate5611.111.1
Modafinil2610.310.3
Liothyronine Sodium710.210.2
Conjugated Estrogens4510.010.0
Rizatriptan Benzoate810.010.0
Clobazam199.910.0
Estrogens, Conjugated459.89.8
Niacin88.78.8
Loratadine And Pseudoephedrine Sulfate58.08.0
Armodafinil127.27.2
Selexipag146.96.9
Oseltamivir46.46.4
Methylphenidate125.35.3
Medroxyprogesterone Acetate164.14.1
Cannabidiol73.83.8
Romosozumab-Aqqg43.73.7
Drospirenone And Ethinyl Estradiol113.23.2
Hydrocodone Bitartrate82.32.3
Adapalene30.20.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.